Robin Jones

505 papers receiving 21.8k citations

Robin Jones's Hit Papers

Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group 2021 · 181 citations
1810+3+7Years since publication2505007501k

Peers

Robin Jones
Comparison fields: 5 of 142
  • Gastroenterology 2.2k
  • Pulmonary and Respiratory Medicine 9.1k
  • Rheumatology 2.2k
  • Cancer Research 1.7k
  • Oncology 2.5k
Replace Stefan Sleijfer with:
Stefan Sleijfer Netherlands
Ian Robert Judson United Kingdom
Robert S. Benjamin United States
Patrick Schöffski Belgium
Piotr Lukasz Rutkowski Poland
Axel Le Cesne France
Stefan Bielack Germany
George D. Demetri United States
George D. Demetri United States
Filip Jankú United States
Robin Jones relative to Stefan Sleijfer Netherlands Stefan Sleijfer's profile →
Citations per field
00.5×2×3×4.1×
Stefan Sleijfer · 1×
Citations per year

Countries citing papers authored by Robin Jones

Since Specialization
Citations

This map shows the geographic impact of Robin Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Jones more than expected).

Fields of papers citing papers by Robin Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Jones. The network helps show where Robin Jones may publish in the future.

Co-authors

The 25 scholars most cited alongside Robin Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robin Jones Line = papers co-authored together Robin Jones links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 531 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hit paper breakdown →
20181096
2
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
Hit paper breakdown →
2021702
3
Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
Hit paper breakdown →
2015681
4
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hit paper breakdown →
2018603
5
Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
Hit paper breakdown →
2016490
6
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hit paper breakdown →
2018438
7 2007381
8
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Hit paper breakdown →
2021374
9
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
Hit paper breakdown →
2020319
10
The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients
Hit paper breakdown →
2020317
11
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
Hit paper breakdown →
2021313
12
Ripretinib in patients with advanced gastrointestinal stromal tumours (INVICTUS): a double-blind, randomised, placebo-controlled, phase 3 trial
Hit paper breakdown →
2020299
13 2005290
14 2007281
15
An update on the management of sporadic desmoid-type fibromatosis: a European Consensus Initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for Research and Treatment of Cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG)
Hit paper breakdown →
2017277
16 2008258
17 2020251
18 2017243
19 2017241
20
Avapritinib in advanced PDGFRA D842V-mutant gastrointestinal stromal tumour (NAVIGATOR): a multicentre, open-label, phase 1 trial
Hit paper breakdown →
2020241

About Robin Jones

Robin Jones is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology, Rheumatology, Oncology and Cancer Research, having authored 531 papers that have together received 22.4k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (252 papers), Gastrointestinal Tumor Research and Treatment (68 papers), Soft tissue tumor case studies (32 papers), Vascular Tumors and Angiosarcomas (21 papers), Breast Cancer Treatment Studies (20 papers), Chemotherapy-induced cardiotoxicity and mitigation (14 papers), Bone Tumor Diagnosis and Treatments (14 papers) and Cancer Immunotherapy and Biomarkers (11 papers). The work is most often cited by research in Gastroenterology (2.2k citations), Pulmonary and Respiratory Medicine (9.1k citations), Rheumatology (2.2k citations), Cancer Research (1.7k citations) and Oncology (2.5k citations). Robin Jones has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Khin Thway, Cyril Fisher, Ian Robert Judson, Paul H. Huang, Jorge Sergio Reis-Filho, Seth M. Pollack, Ian E. Smith, Jonathan Christopher Noujaim, Omar Al‐Muderis and Anastasia Constantinidou. Their work appears in journals such as Annals of Oncology, Future Oncology, European Journal of Cancer, Cancers and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact